Study ID: LAQ-MS-201
Study Title
- A Multinational, Randomized, Double-blind, ParFemale, Maleel-group, Placebo-controlled Study Assessing the Safety and Tolerability
Teva Identifier
- LAQ-MS-201
ClinicalTrials.gov Identifier
- NCT01404117
Study Status
- Withdrawn
Trial Condition(s)
- Relapsing Multiple Sclerosis
Interventions
- Drug: Laquinimod 0.6 | Drug: Laquinimod 1.2 | Other: Glatiramer Acetate or interferon-beta+ Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- 03/01/2012 - 01/01/2014
Phase
- Phase 2
Study Type
Interventional
